OUR STORE IS CLOSED ON ANZAC DAY: THURSDAY 25 APRIL

Close Notification

Your cart does not contain any items

Quantitative Imaging Tools for Lung Cancer Drug Assessment

James L. Mulshine (Rush University Medical Center in Chicago) Thomas M. Baer

$298.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Wiley-OSA
01 April 2008
Presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well as contributions from recognized experts in CAD, medical information technology systems, regulatory procedure, x-ray standards development, and clinical trial design. These expert contributors discuss the current state of the art and provide a road map for directing further research in lung cancer as well as other organ systems.

Edited by:   ,
Imprint:   Wiley-OSA
Country of Publication:   United States
Dimensions:   Height: 241mm,  Width: 163mm,  Spine: 17mm
Weight:   426g
ISBN:   9780470118801
ISBN 10:   0470118806
Pages:   176
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

James L. Mulshine, MD, is a Professor of Internal Medicine, Associate Provost of Research and Vice President, Rush University Medical Center in Chicago, Illinois.?In this position, Dr. Mulshine is the primary academic officer responsible for managing research activities at Rush University Medical School. He is an internationally recognized expert on lung cancer.?Over the last few years, Dr. Mulshine has been working with a range of organizations to accelerate the use of high resolution spiral CT in the quantitative evaluation of drug response for early lung cancer.

See Also